Lexicon Pharmaceuticals
LXRX
$1.58
Share price
0.00%
Change (1 day)
-33.89%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) Fails to deliver data
Key failure to deliver metrics for Lexicon Pharmaceuticals :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $2.07 M
- Last 3 months FTD volume: $14.09 M
- Last year FTD volume: $23.42 M
Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015
Volume in USD (price x number of shares), data since 2015Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $14 M | 46.33% |
| 2023 | $9.57 M | 315.88% |
| 2022 | $2.3 M | -91.22% |
| 2021 | $26.2 M | 1.63% |
| 2020 | $25.78 M | 21.18% |
| 2019 | $21.27 M | -6.95% |
| 2018 | $22.86 M | -27.5% |
| 2017 | $31.53 M | 18.35% |
| 2016 | $26.64 M | 59.83% |
| 2015 | $16.67 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $0.18 B | $0.40 B | 🇺🇸 USA |
 Illumina ILMN | $1.26 M | $0.10 B | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $59.04 M | $0.14 B | 🇺🇸 USA |
 Ultragenyx RARE | $3.42 M | $16.85 M | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.58 M | $3.53 M | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $3.36 M | $8.49 M | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | N/A | $0.94 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.05 M | $0.25 M | 🇺🇸 USA |